Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

5

Portfolio Exits

2

About TWB Investment Partners

TWB Investment Partners is an investment firm based in Seattle, Washington.

TWB Investment Partners Headquarter Location

1201 Third Avenue 40th Floor

Seattle, Washington, 98101,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest TWB Investment Partners News

Attune Medical Closes $10 Million Series C Financing To Support Continued Global Adoption of Esophageal Temperature Management Device

Oct 17, 2017

The Series C Financing features continued participation by existing investors such as the Gopher Angels, the Heartland Angels, and TWB Investment Partners, along with many Attune Medical associates. New investors include the PFG Group, plus several other private investors. “Being located in Minnesota, one of the more significant medical device hubs in the world, our investment team reviews many device investment opportunities,“ commented David Russick, Founder of Gopher Angels. Paul Hansen, former President of 3M Mexico, and member of Gopher Angels, notes “We are investing significantly in Attune Medical for the third time based on the strength of the company’s continued overall market uptake, increasing use on a per-hospital basis, and accelerating expansion into warming applications in the OR for longer, more involved cases when patient warming is a challenge. We are proud to continue to support Attune Medical's groundbreaking work in improving temperature control for patients.“ John Schreiner, a member of the TWB Investment Partnership and the Perkins Coie attorney who represented Attune in the financing, commented, “Attune Medical’s EnsoETM is shifting the paradigm in targeted temperature management solutions in the healthcare space. This simple, cost-effective and safe platform represents a new, and we think better, option for clinicians who need to cool or warm patients.” Attune Medical’s Chief Operating Officer, Keith Warner, commented, “This funding from investors sends a strong statement with respect to their confidence in Attune’s success as well as our opportunity for continued growth. Attune’s proven product requires no additional capital equipment purchase, and we are pleased to report continued adoption by a growing number of major hospitals in the U.S. and around the world.” Formerly known as Advanced Cooling Therapy, Attune Medical has developed proprietary medical device technology that simplifies access to the patient’s core to efficiently control core temperature. Whether warming or cooling, the company optimizes, or “tunes,” patient temperature safely and effectively. Attune’s initial product, the EnsoETM (formerly Esophageal Cooling Device or ECD), is designed to modulate and control patient temperature through a single-use, fully-enclosed system that is inserted into the esophagus. Two lumens attach to an external heat exchange unit while a third, independent, lumen simultaneously allows gastric decompression and drainage. The EnsoETM can be rapidly placed by most trained healthcare professionals, in similar fashion to a standard gastric tube, and can be used to control patient temperature in the operating room, recovery room, emergency room, and/or intensive care unit. No other products on the market are approved to use the esophageal environment for whole-body temperature modulation. Attune Medical (as Advanced Cooling Therapy) received US FDA de novo clearance for the EnsoETM (Esophageal Cooling Device or ECD) in 2015 for use with the Medi-Therm III by Stryker®. The company received FDA 510(k) clearance in 2016 for use with the Blanketrol® II and III Hyper-Hypothermia systems made by Cincinnati Sub-Zero, a Gentherm Company, and FDA 510(k) clearance for use with the Altrix System by Stryker® in 2017. It received its CE Mark in Europe in 2014, with an expanded indication for use up to 120 hours in 2016 and a CE Mark for use with the Altrix System by Stryker® in 2017. It is also licensed for sale in Canada and Australia. ABOUT GOPHER ANGELS: Gopher Angels is a network of accredited investors seeking to invest capital and expertise in early stage Midwest-based businesses. Gopher Angels members are experienced entrepreneurs, business leaders, and investors who have helped build successful businesses, particularly in the arena of life sciences and medical devices. Gopher Angels members have diverse industry and business expertise, resulting in a well-rounded and networked group of experience and talent. ABOUT HEARTLAND ANGELS: Heartland Angels is an open network of individuals looking to assist seed and early stage companies in obtaining investment capital and in furthering their innovations. Our mission is to be a catalyst in the process of innovation. We do this by creating forums in which human, intellectual and financial capital are joined for a common purpose. ABOUT TWB INVESTMENT PARTNERSHIP: TWB Investment Partnership is an investment vehicle comprised of accredited Perkins Coie attorneys. With more than 950 lawyers in 19 offices across the United States and Asia, Perkins Coie represents great companies across a wide range of industries and stages of growth—from start-ups to FORTUNE 50 corporations. ABOUT THE PFG GROUP: The PFG Group, LLC is a Chicago based team of highly experienced and successful entrepreneurs seeking to invest in or acquire emerging growth companies. View source version on businesswire.com: http://www.businesswire.com/news/home/20171017005454/en/ for Attune Medical

TWB Investment Partners Investments

5 Investments

TWB Investment Partners has made 5 investments. Their latest investment was in Attune Medical as part of their Series C on October 10, 2017.

CBI Logo

TWB Investment Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/17/2017

Series C

Attune Medical

$10M

No

Gopher Angels, Heartland Angels, PFG Group, and Undisclosed Investors

8

10/17/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

8/22/2014

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/4/2005

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

6/17/1999

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/17/2017

10/17/2017

8/22/2014

3/4/2005

6/17/1999

Round

Series C

Seed VC

Series A

Unattributed VC - II

Unattributed VC - II

Company

Attune Medical

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$10M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Gopher Angels, Heartland Angels, PFG Group, and Undisclosed Investors

Sources

8

10

10

10

10

TWB Investment Partners Portfolio Exits

2 Portfolio Exits

TWB Investment Partners has 2 portfolio exits. Their latest portfolio exit was Torch on December 10, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2020

Acquired

3

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

12/10/2020

00/00/0000

Exit

Acquired

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Sources

3

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.